Viridian Therapeutics, Inc. Stock Forecast
Viridian Therapeutics, Inc. stock upgraded to Hold/Accumulate.
(Updated on Jun 28, 2024)
The Viridian Therapeutics, Inc. stock price gained 4.43% on the last trading day (Friday, 28th Jun 2024), rising from $12.15 to $12.69. During the last trading day the stock fluctuated 3.02% from a day low at $12.58 to a day high of $12.96. The price has been going up and down for this period, and there has been a 1.31% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 6 thousand shares were bought and sold for approximately $78.78 thousand.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $12.83 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -25.58% during the next 3 months and, with a 90% probability hold a price between $7.12 and $9.55 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
0K1R.L Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, June 04, 2024, and so far it has risen 9.21%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Viridian Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Viridian Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $12.77. On a fall, the stock will find some support from the short-term average at $12.57. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.
Support, Risk & Stop-loss for Viridian Therapeutics, Inc. stock
Viridian Therapeutics, Inc. finds support from accumulated volume at $12.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.380 between high and low, or 3.02%. For the last week, the stock has had daily average volatility of 3.68%.
Our recommended stop-loss: $12.20 (-3.88%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 37 days ago.)
Trading Expectations (0K1R.L) For The Upcoming Trading Day Of Monday 1st
For the upcoming trading day on Monday, 1st we expect Viridian Therapeutics, Inc. to open at $12.74, and during the day (based on 14 day Average True Range), to move between $12.13 and $13.25, which gives a possible trading interval of +/-$0.556 (+/-4.38%) up or down from last closing price. If Viridian Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.76% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $12.63 (0.47%) than the resistance at $13.11 (3.31%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Viridian Therapeutics, Inc. stock A Buy?
Viridian Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.000 Hold/Accumulate Upgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Opening Price for Viridian Therapeutics, Inc. of Monday, July 1, 2024
| Fair opening price July 1, 2024 | Current price |
|---|---|
| $12.74 ( 0.420%) | $12.69 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for 0K1R.L
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 13.12 | 3.41% |
| R2 | 12.98 | 2.27% |
| R1 | 12.89 | 1.56% |
| Price | 12.69 | |
| S1 | 12.60 | -0.724% |
| S2 | 12.51 | -1.43% |
| S3 | 12.36 | -2.57% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 13.93 | 9.77% |
| R2 | 13.16 | 3.70% |
| R1 | 13.11 | 3.31% |
| Price | 12.69 | |
| S1 | 12.63 | -0.473% |
| S2 | 12.15 | -4.24% |
| S3 | 11.86 | -6.54% |
FAQ
Click here for our free guide on how to buy Viridian Therapeutics, Inc. Stock.
